Society guideline links: Langerhans cell histiocytosis

Introduction — This topic includes links to society and government-sponsored guidelines from selected countries and regions around the world. We will update these links periodically; newer versions of some guidelines may be available on each society's website. Some societies may require users to log in to access their guidelines.

The recommendations in the following guidelines may vary from those that appear in UpToDate topic reviews. Readers who are looking for UpToDate topic reviews should use the UpToDate search box to find the relevant content.

Links to related guidelines are provided separately. (See "Society guideline links: Interstitial lung disease".)

International

●International expert consensus recommendations for the diagnosis and treatment of Langerhans cell histiocytosis in adults (2022)

United States

●Mayo Clinic Histiocytosis Working Group: Consensus statement for the diagnosis and evaluation of adult patients with histiocytic neoplasms – Erdheim-Chester disease, Langerhans cell histiocytosis, and Rosai-Dorfman disease (2019)

Europe

●European Society of Cardiology (ESC)/European Respiratory Society (ERS): Guidelines for the diagnosis and treatment of pulmonary hypertension (2022)

●Euro-Histio-Net (EHN): Langerhans cell histiocytosis (LCH) – Guidelines for diagnosis, clinical work-up, and treatment for patients till the age of 18 years (2013)

●EHN: Recommendations from an expert panel for the management of adult patients with Langerhans cell histiocytosis (2013)